Javascript must be enabled to continue!
Preparation and Characterization of Carvedilol Solid Dispersion by Kneading Method
View through CrossRef
Solid dispersion using hydrophilic carrier is one of the approaches that has a potential to increase solubility, dissolution rate and consequently the oral bioavailability of poorly-water soluble drugs. In this study, class II drug "Carvedilol" (CVD) was used because of its poor solubility, it serves as a model drug that contributes to irregular dissolution and limited bioavailability. CVD: PVP K30 solid dispersion formulations SD1, SD2 and SD3 were prepared by kneading method at different weight ratios ,1:1; 1:2 and 1:4 respectively and evaluated for drug content, solubility and dissolution rate. Kneading method enhances the stability of drugs and suitable for processing thermolabile substances. The optimum solid dispersion ratio was characterized also for drug-carrier interaction by FTIR spectroscopy, and crystallinity by SEM and PXRD and compared with physical mixture and pure drug powder.
The results showed that the solubility of carvedilol increased by increasing the proportion of PVP K30 used in the dispersion of the drug. On the other hand, dissolution study revealed a significant enhancement in the dissolution rate of the drug using solid dispersion compared to pure drug and physical mixture. X-ray diffraction of the solid dispersion suggest that the drug's transformation from crystalline to amorphous form may be responsible for the observed improvement in dissolving rate. The carvedilol solid dispersion improved the solubility and dissolution, which depend on the carrier concentration ratio. The dissolution of drugs increased with an increase in carrier content. The studies of PXRD, SEM, and FTIR revealed the amorphous nature of the drug in solid dispersion. The solid dispersion by kneading approach using PVP K30 as a carrier is a potential method for improving CVD's solubility and dissolution rate.
Al Mustansiriyah University - College of Pharmacy
Title: Preparation and Characterization of Carvedilol Solid Dispersion by Kneading Method
Description:
Solid dispersion using hydrophilic carrier is one of the approaches that has a potential to increase solubility, dissolution rate and consequently the oral bioavailability of poorly-water soluble drugs.
In this study, class II drug "Carvedilol" (CVD) was used because of its poor solubility, it serves as a model drug that contributes to irregular dissolution and limited bioavailability.
CVD: PVP K30 solid dispersion formulations SD1, SD2 and SD3 were prepared by kneading method at different weight ratios ,1:1; 1:2 and 1:4 respectively and evaluated for drug content, solubility and dissolution rate.
Kneading method enhances the stability of drugs and suitable for processing thermolabile substances.
The optimum solid dispersion ratio was characterized also for drug-carrier interaction by FTIR spectroscopy, and crystallinity by SEM and PXRD and compared with physical mixture and pure drug powder.
The results showed that the solubility of carvedilol increased by increasing the proportion of PVP K30 used in the dispersion of the drug.
On the other hand, dissolution study revealed a significant enhancement in the dissolution rate of the drug using solid dispersion compared to pure drug and physical mixture.
X-ray diffraction of the solid dispersion suggest that the drug's transformation from crystalline to amorphous form may be responsible for the observed improvement in dissolving rate.
The carvedilol solid dispersion improved the solubility and dissolution, which depend on the carrier concentration ratio.
The dissolution of drugs increased with an increase in carrier content.
The studies of PXRD, SEM, and FTIR revealed the amorphous nature of the drug in solid dispersion.
The solid dispersion by kneading approach using PVP K30 as a carrier is a potential method for improving CVD's solubility and dissolution rate.
Related Results
Carvedilol ameliorates experimental atherosclerosis by inhibiting the NLRP3 inflammasome
Carvedilol ameliorates experimental atherosclerosis by inhibiting the NLRP3 inflammasome
Abstract
Objective: To investigate the protective effect of carvedilol against atherosclerosis by inhibiting the NLRP3 inflammasome.
Methods:In vitro experiments, human umb...
The dose dependency of the alpha‐ and beta‐adrenoceptor antagonist activity of carvedilol in man.
The dose dependency of the alpha‐ and beta‐adrenoceptor antagonist activity of carvedilol in man.
1. The alpha‐ and beta‐adrenoceptor antagonist activity of carvedilol, a beta‐adrenoceptor antagonist with vasodilating properties, and labetalol were investigated in 10 healthy ma...
Effect of Lercanidipine on the Pharmacokinetics‐Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease
Effect of Lercanidipine on the Pharmacokinetics‐Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease
AbstractThis study evaluates the carvedilol‐lercanidipine drug interaction, and the influence of chronic kidney disease (CKD) on both drugs. Patients with high blood pressure (8 wi...
Clinical study evaluating the gastroprotective effect of carvedilol in patients with ischemic heart disease on aspirin therapy
Clinical study evaluating the gastroprotective effect of carvedilol in patients with ischemic heart disease on aspirin therapy
Abstract
Background and purpose
Despite its therapeutic benefits in ischemic heart disease (IHD) patients, using aspirin represents a significant...
Dispersion Compensation in Optical Fiber: A Review
Dispersion Compensation in Optical Fiber: A Review
A cylindrical-shaped dielectric waveguide is what an optical fiber is. The core-cladding interface confines light, as electromagnetic (EM) energy, within its surface and guides lig...
Both Carvedilol and Nebivolol May Improve Platelet Function and Prothrombotic State in Patients With Nonischemic Heart Failure
Both Carvedilol and Nebivolol May Improve Platelet Function and Prothrombotic State in Patients With Nonischemic Heart Failure
It is unclear whether carvedilol and nebivolol will produce different effects on platelet function and prothrombotic state in heart failure (HF). Thus, we compared their effects on...
Effect of valsartan and carvedilol on TNFα, IL-6 and angiotensin α on geriatric chronic heart failure
Effect of valsartan and carvedilol on TNFα, IL-6 and angiotensin α on geriatric chronic heart failure
Objective
To observe the effect of Valsartan and carvedilol on TNFα, IL-6 and angiotensin II (Ang II) in geriatric chronic heart failure (CHF).
...
Carvedilol Produces Sustained Long‐Term Benefits: Follow‐Up at 12 Years
Carvedilol Produces Sustained Long‐Term Benefits: Follow‐Up at 12 Years
The authors measured long‐term outcomes of patients who initiated carvedilol between 1990 and 1992 to test the hypothesis that carvedilol produces sustained benefits in heart failu...

